<?xml version="1.0" encoding="utf-8"?>
<journal>
<title>Caspian Journal of Internal Medicine</title>
<title_fa></title_fa>
<short_title>Caspian J Intern Med</short_title>
<subject>Medical Sciences</subject>
<web_url>http://caspjim.com</web_url>
<journal_hbi_system_id>1</journal_hbi_system_id>
<journal_hbi_system_user>admin</journal_hbi_system_user>
<journal_id_issn>2008-6164</journal_id_issn>
<journal_id_issn_online>2008-6172</journal_id_issn_online>
<journal_id_pii>8</journal_id_pii>
<journal_id_doi>10.22088/cjim</journal_id_doi>
<journal_id_iranmedex></journal_id_iranmedex>
<journal_id_magiran></journal_id_magiran>
<journal_id_sid>14</journal_id_sid>
<journal_id_nlai>8888</journal_id_nlai>
<journal_id_science>13</journal_id_science>
<language>en</language>
<pubdate>
	<type>jalali</type>
	<year>1394</year>
	<month>7</month>
	<day>1</day>
</pubdate>
<pubdate>
	<type>gregorian</type>
	<year>2015</year>
	<month>10</month>
	<day>1</day>
</pubdate>
<volume>6</volume>
<number>4</number>
<publish_type>online</publish_type>
<publish_edition>1</publish_edition>
<article_type>fulltext</article_type>
<articleset>
	<article>


	<language>en</language>
	<article_id_doi></article_id_doi>
	<title_fa></title_fa>
	<title>A Study of arbutin protective effect on cyclosporin A-induced oxidative damage</title>
	<subject_fa>Biochimestry</subject_fa>
	<subject>Biochimestry</subject>
	<content_type_fa>Original Article</content_type_fa>
	<content_type>Original Article</content_type>
	<abstract_fa></abstract_fa>
	<abstract>&lt;p align=&quot;justify&quot;&gt;&lt;font face=&quot;Times New Roman&quot; size=&quot;3&quot;&gt; &lt;/font&gt;&lt;font face=&quot;Times New Roman&quot;&gt;&lt;b&gt;&lt;i&gt;&lt;span style=&quot;color: blue font-size: 10pt&quot;&gt;&lt;font face=&quot;times new roman,times,serif&quot;&gt;Background: &lt;/font&gt;&lt;/span&gt;&lt;/i&gt;&lt;/b&gt;&lt;span style=&quot;font-size: 10pt&quot;&gt;&lt;font face=&quot;times new roman,times,serif&quot;&gt;Cyclosporine&lt;/font&gt;&lt;font face=&quot;times new roman,times,serif&quot;&gt; A (CsA) is a potent immunosuppressant drug with therapeutic and toxic actions. The use of CsA is limited by its toxicity. Several researchers had &lt;/font&gt;&lt;/span&gt;&lt;font face=&quot;times new roman,times,serif&quot;&gt;&lt;span style=&quot;font-size: 10pt mso-fareast-font-family: AdvEPSTIM&quot;&gt;&lt;font face=&quot;times new roman,times,serif&quot;&gt;proposed&lt;/font&gt;&lt;/span&gt;&lt;span style=&quot;font-size: 10pt&quot;&gt;&lt;font face=&quot;times new roman,times,serif&quot;&gt; that oxidative stress&lt;/font&gt; &lt;font face=&quot;times new roman,times,serif&quot;&gt;could play an important role in CsA-induced toxicity&lt;/font&gt;.&lt;/span&gt;&lt;span style=&quot;font-size: 10pt mso-fareast-font-family: AdvEPSTIM&quot;&gt; &lt;/span&gt;&lt;/font&gt;&lt;span style=&quot;font-size: 10pt&quot;&gt;&lt;font face=&quot;times new roman,times,serif&quot;&gt;Arbutin&lt;/font&gt;&lt;/span&gt;&lt;span style=&quot;font-size: 10pt mso-fareast-font-family: AdvEPSTIM&quot;&gt;&lt;font face=&quot;times new roman,times,serif&quot;&gt;&lt;font face=&quot;times new roman,times,serif&quot;&gt;&lt;font face=&quot;times new roman,times,serif&quot;&gt; &lt;/font&gt;has&lt;/font&gt; recently been&lt;/font&gt; &lt;font face=&quot;times new roman,times,serif&quot;&gt;shown to possess antioxidative and free radical scavenging abilities.&lt;span new=&quot;&quot; style=&quot;font-family:&quot; times=&quot;&quot;&gt;The present study was designed to investigate the in vivo&lt;i&gt; &lt;/i&gt;effects of arbutin&lt;/span&gt;&lt;span new=&quot;&quot; style=&quot;font-family:&quot; times=&quot;&quot;&gt; &lt;/span&gt;&lt;span new=&quot;&quot; style=&quot;font-family:&quot; times=&quot;&quot;&gt;on lipid peroxidation and antioxidant capacity in the serum of cyclosporine treated rats.&lt;/span&gt;&lt;/font&gt;&lt;/span&gt;&lt;/font&gt;&lt;/p&gt;

&lt;p&gt;&lt;font face=&quot;Times New Roman&quot; size=&quot;3&quot;&gt; &lt;/font&gt;&lt;font face=&quot;times new roman,times,serif&quot;&gt;&lt;b&gt;&lt;i&gt;&lt;span style=&quot;color: blue font-size: 10pt&quot;&gt;&lt;font face=&quot;times new roman,times,serif&quot;&gt;Methods:&lt;/font&gt;&lt;/span&gt;&lt;/i&gt;&lt;/b&gt;&lt;span style=&quot;font-size: 10pt&quot;&gt; &lt;font face=&quot;times new roman,times,serif&quot;&gt;Adult m&lt;/font&gt;&lt;/span&gt;&lt;font face=&quot;times new roman,times,serif&quot;&gt;&lt;span style=&quot;font-size: 10pt mso-fareast-font-family: AdvEPSTIM&quot;&gt;&lt;font face=&quot;times new roman,times,serif&quot;&gt;ale Wistar&lt;/font&gt;&lt;/span&gt;&lt;span style=&quot;font-size: 10pt&quot;&gt;&lt;font face=&quot;times new roman,times,serif&quot;&gt; rats were&lt;/font&gt; &lt;font face=&quot;times new roman,times,serif&quot;&gt;divided into six groups (n=8/group):&lt;/font&gt;&lt;/span&gt;&lt;font face=&quot;times new roman,times,serif&quot;&gt;&lt;font face=&quot;times new roman,times,serif&quot;&gt;&lt;font face=&quot;times new roman,times,serif&quot;&gt;&lt;span style=&quot;font-size: 10pt mso-fareast-font-family: AdvEPSTIM&quot;&gt; &lt;font face=&quot;times new roman,times,serif&quot;&gt;(I) control&lt;/font&gt; &lt;font face=&quot;times new roman,times,serif&quot;&gt;(no CsA and &lt;/font&gt;&lt;/span&gt;&lt;span style=&quot;font-size: 10pt&quot;&gt;&lt;font face=&quot;times new roman,times,serif&quot;&gt;arbutin&lt;/font&gt;&lt;/span&gt;&lt;/font&gt;&lt;/font&gt;&lt;/font&gt;&lt;span style=&quot;font-size: 10pt mso-fareast-font-family: AdvEPSTIM&quot;&gt;&lt;font face=&quot;times new roman,times,serif&quot;&gt; administration), (II and &lt;/font&gt;III)&lt;/span&gt;&lt;span style=&quot;font-size: 10pt&quot;&gt; &lt;font face=&quot;times new roman,times,serif&quot;&gt;were treated subcutaneously &lt;/font&gt;&lt;/span&gt;&lt;font face=&quot;times new roman,times,serif&quot;&gt;&lt;font face=&quot;times new roman,times,serif&quot;&gt;&lt;span style=&quot;font-size: 10pt mso-fareast-font-family: AdvEPSTIM&quot;&gt;&lt;font face=&quot;times new roman,times,serif&quot;&gt;(Sc) &lt;/font&gt;&lt;/span&gt;&lt;span style=&quot;font-size: 10pt&quot;&gt;&lt;font face=&quot;times new roman,times,serif&quot;&gt;with arbutin&lt;/font&gt; &lt;font face=&quot;times new roman,times,serif&quot;&gt;(50,100 mg/kg/bw),&lt;/font&gt;&lt;/span&gt;&lt;/font&gt;&lt;span style=&quot;font-size: 10pt mso-fareast-font-family: AdvEPSTIM&quot;&gt; &lt;font face=&quot;times new roman,times,serif&quot;&gt;respectively&lt;/font&gt;&lt;/span&gt;&lt;/font&gt;&lt;font face=&quot;times new roman,times,serif&quot;&gt;&lt;span style=&quot;font-size: 10pt&quot;&gt;,&lt;/span&gt;&lt;span style=&quot;font-size: 10pt mso-fareast-font-family: AdvEPSTIM&quot;&gt; (IV) administered CsA (25&lt;/span&gt;&lt;span style=&quot;font-size: 10pt&quot;&gt; mg/kg/bw)&lt;/span&gt;&lt;/font&gt;&lt;span style=&quot;font-size: 10pt mso-fareast-font-family: AdvEPSTIM&quot;&gt; &lt;/span&gt;&lt;font face=&quot;times new roman,times,serif&quot;&gt;&lt;span style=&quot;font-size: 10pt&quot;&gt;&lt;font face=&quot;times new roman,times,serif&quot;&gt;intraperitoneally &lt;/font&gt;&lt;font face=&quot;times new roman,times,serif&quot;&gt;(IP)&lt;/font&gt;&lt;/span&gt;&lt;span style=&quot;font-size: 10pt mso-fareast-font-family: AdvEPSTIM&quot;&gt;&lt;font face=&quot;times new roman,times,serif&quot;&gt;, (V and VI) received the combination&lt;/font&gt; &lt;font face=&quot;times new roman,times,serif&quot;&gt;of CsA (25&lt;/font&gt;&lt;/span&gt;&lt;font face=&quot;times new roman,times,serif&quot;&gt;&lt;span style=&quot;font-size: 10pt&quot;&gt; &lt;font face=&quot;times new roman,times,serif&quot;&gt;mg/kg/bw)&lt;/font&gt;&lt;/span&gt;&lt;font face=&quot;times new roman,times,serif&quot;&gt;&lt;span style=&quot;font-size: 10pt mso-fareast-font-family: AdvEPSTIM&quot;&gt; &lt;font face=&quot;times new roman,times,serif&quot;&gt;i.p&lt;/font&gt;&lt;/span&gt;&lt;font face=&quot;times new roman,times,serif&quot;&gt;&lt;span style=&quot;font-size: 10pt&quot;&gt; &lt;font face=&quot;times new roman,times,serif&quot;&gt;and arbutin&lt;/font&gt;&lt;/span&gt;&lt;font face=&quot;times new roman,times,serif&quot;&gt;&lt;span style=&quot;font-size: 10pt mso-fareast-font-family: AdvEPSTIM&quot;&gt; &lt;/span&gt;&lt;font face=&quot;times new roman,times,serif&quot;&gt;&lt;font face=&quot;times new roman,times,serif&quot;&gt;&lt;font face=&quot;times new roman,times,serif&quot;&gt;&lt;span style=&quot;font-size: 10pt&quot;&gt;&lt;font face=&quot;times new roman,times,serif&quot;&gt;(50,100 mg/kg/bw)&lt;/font&gt;&lt;/span&gt;&lt;span style=&quot;font-size: 10pt mso-fareast-font-family: AdvEPSTIM&quot;&gt; &lt;font face=&quot;times new roman,times,serif&quot;&gt;Sc&lt;/font&gt;&lt;/span&gt;&lt;/font&gt;&lt;/font&gt;&lt;span style=&quot;font-size: 10pt&quot;&gt;&lt;font face=&quot;times new roman,times,serif&quot;&gt; daily&lt;/font&gt;,&lt;/span&gt;&lt;span style=&quot;font-size: 10pt mso-fareast-font-family: AdvEPSTIM&quot;&gt; respectively&lt;/span&gt;&lt;/font&gt;&lt;/font&gt;&lt;/font&gt;&lt;/font&gt;&lt;/font&gt;&lt;/font&gt;&lt;/font&gt;&lt;span style=&quot;font-size: 10pt&quot;&gt;&lt;font face=&quot;times new roman,times,serif&quot;&gt;. At the end of the treatment (after3 weeks), serum lipid peroxidation was measured by thiobarbituric acid-reacting substances (TBARS) and serum total antioxidant capacity (ferric reducing ability of plasma [FRAP]) was assayed based on&lt;/font&gt; spectrophotometric method.&lt;/span&gt;&lt;/font&gt;&lt;/p&gt;

&lt;p&gt;&lt;font face=&quot;Times New Roman&quot; size=&quot;3&quot;&gt; &lt;/font&gt;&lt;font face=&quot;Times New Roman&quot;&gt;&lt;font face=&quot;times new roman,times,serif&quot;&gt;&lt;b&gt;&lt;i&gt;&lt;span style=&quot;color: blue font-size: 10pt&quot;&gt;&lt;font face=&quot;times new roman,times,serif&quot;&gt;Results:&lt;/font&gt;&lt;/span&gt;&lt;/i&gt;&lt;/b&gt;&lt;span style=&quot;font-size: 10pt&quot;&gt; &lt;font face=&quot;times new roman,times,serif&quot;&gt;TBARS had been significantly increased by CsA administration compared with control rats. Arbutin (50mg/kg/bw) completely prevented&lt;/font&gt; &lt;font face=&quot;times new roman,times,serif&quot;&gt;this effect, but arbutin (100 mg/kg/bw) alone or in combination with CsA significantly increased lipid peroxidation compared with controls.&lt;/font&gt;&lt;/span&gt;&lt;/font&gt;&lt;/font&gt;&lt;/p&gt;

&lt;p&gt;&lt;font face=&quot;Times New Roman&quot; size=&quot;3&quot;&gt; &lt;/font&gt;&lt;font face=&quot;Times New Roman&quot;&gt;&lt;b&gt;&lt;i&gt;&lt;span style=&quot;color: blue font-size: 10pt&quot;&gt;&lt;font face=&quot;times new roman,times,serif&quot;&gt;Conclusion:&lt;/font&gt; &lt;/span&gt;&lt;/i&gt;&lt;/b&gt;&lt;font face=&quot;times new roman,times,serif&quot;&gt;&lt;span style=&quot;font-size: 10pt&quot;&gt;&lt;font face=&quot;times new roman,times,serif&quot;&gt;Our data indicate that arbutin (50mg/kg/bw) had protective&lt;/font&gt;&lt;font face=&quot;times new roman,times,serif&quot;&gt; effect in the CsA-induced toxicity but high concentration of arbutin (100mg/kg/bw) showed meaningful oxidative&lt;/font&gt;&lt;/span&gt;&lt;font face=&quot;times new roman,times,serif&quot;&gt;&lt;span style=&quot;font-size: 10pt mso-fareast-font-family: AdvEPSTIM&quot;&gt; &lt;font face=&quot;times new roman,times,serif&quot;&gt;and&lt;/font&gt;&lt;/span&gt;&lt;span style=&quot;font-size: 10pt&quot;&gt;&lt;font face=&quot;times new roman,times,serif&quot;&gt; lipoperoxidative effects.&lt;/font&gt;&lt;/span&gt;&lt;/font&gt;&lt;/font&gt;&lt;/font&gt;&lt;/p&gt;

&lt;p&gt;&lt;font face=&quot;Times New Roman&quot; size=&quot;3&quot;&gt; &lt;/font&gt;&lt;/p&gt;
</abstract>
	<keyword_fa></keyword_fa>
	<keyword>cyclosporin A, oxidative stress, arbutin, anti-oxidant</keyword>
	<start_page>196</start_page>
	<end_page>200</end_page>
	<web_url>http://caspjim.com/browse.php?a_code=A-10-266-1&amp;slc_lang=en&amp;sid=1</web_url>


<author_list>
	<author>
	<first_name>Fatemeh</first_name>
	<middle_name></middle_name>
	<last_name>Khadir</last_name>
	<suffix></suffix>
	<first_name_fa></first_name_fa>
	<middle_name_fa></middle_name_fa>
	<last_name_fa></last_name_fa>
	<suffix_fa></suffix_fa>
	<email>khadirfatemeh@yahoo.com</email>
	<code>10031947532846004211</code>
	<orcid>10031947532846004211</orcid>
	<coreauthor>No</coreauthor>
	<affiliation>Babol University of Medical sciences</affiliation>
	<affiliation_fa></affiliation_fa>
	 </author>


	<author>
	<first_name>Mahdi</first_name>
	<middle_name></middle_name>
	<last_name>Pouramir</last_name>
	<suffix></suffix>
	<first_name_fa></first_name_fa>
	<middle_name_fa></middle_name_fa>
	<last_name_fa></last_name_fa>
	<suffix_fa></suffix_fa>
	<email>pouramir@yahoo.com</email>
	<code>10031947532846004212</code>
	<orcid>10031947532846004212</orcid>
	<coreauthor>Yes
</coreauthor>
	<affiliation>Babol University of Medical sciences</affiliation>
	<affiliation_fa></affiliation_fa>
	 </author>


	<author>
	<first_name>Gholamali</first_name>
	<middle_name></middle_name>
	<last_name>Joorsaraie</last_name>
	<suffix></suffix>
	<first_name_fa></first_name_fa>
	<middle_name_fa></middle_name_fa>
	<last_name_fa></last_name_fa>
	<suffix_fa></suffix_fa>
	<email>alijorsara@yahoo.com</email>
	<code>10031947532846004213</code>
	<orcid>10031947532846004213</orcid>
	<coreauthor>No</coreauthor>
	<affiliation>Babol University of Medical sciences</affiliation>
	<affiliation_fa></affiliation_fa>
	 </author>


	<author>
	<first_name>Farideh</first_name>
	<middle_name></middle_name>
	<last_name>Feizi</last_name>
	<suffix></suffix>
	<first_name_fa></first_name_fa>
	<middle_name_fa></middle_name_fa>
	<last_name_fa></last_name_fa>
	<suffix_fa></suffix_fa>
	<email>faridehfeizi@yahoo.com</email>
	<code>10031947532846004214</code>
	<orcid>10031947532846004214</orcid>
	<coreauthor>No</coreauthor>
	<affiliation>Babol University of Medical sciences</affiliation>
	<affiliation_fa></affiliation_fa>
	 </author>


	<author>
	<first_name>Hadi</first_name>
	<middle_name></middle_name>
	<last_name>Sorkhi</last_name>
	<suffix></suffix>
	<first_name_fa></first_name_fa>
	<middle_name_fa></middle_name_fa>
	<last_name_fa></last_name_fa>
	<suffix_fa></suffix_fa>
	<email>hadisorkhi@bprc.ir</email>
	<code>10031947532846004215</code>
	<orcid>10031947532846004215</orcid>
	<coreauthor>No</coreauthor>
	<affiliation>Babol University of Medical sciences</affiliation>
	<affiliation_fa></affiliation_fa>
	 </author>


	<author>
	<first_name>Fatemeh</first_name>
	<middle_name></middle_name>
	<last_name>Yousefi</last_name>
	<suffix></suffix>
	<first_name_fa></first_name_fa>
	<middle_name_fa></middle_name_fa>
	<last_name_fa></last_name_fa>
	<suffix_fa></suffix_fa>
	<email>gln.yousefi@gmail.com</email>
	<code>10031947532846004216</code>
	<orcid>10031947532846004216</orcid>
	<coreauthor>No</coreauthor>
	<affiliation>Babol University of Medical sciences</affiliation>
	<affiliation_fa></affiliation_fa>
	 </author>


</author_list>


	</article>
</articleset>
</journal>
